CN102106991B - 一种用于中晚期肝癌化疗栓塞后的药 - Google Patents
一种用于中晚期肝癌化疗栓塞后的药 Download PDFInfo
- Publication number
- CN102106991B CN102106991B CN201110027563.6A CN201110027563A CN102106991B CN 102106991 B CN102106991 B CN 102106991B CN 201110027563 A CN201110027563 A CN 201110027563A CN 102106991 B CN102106991 B CN 102106991B
- Authority
- CN
- China
- Prior art keywords
- radix
- grams
- medicine
- rhizoma atractylodis
- hepatocellular carcinoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 37
- 230000010109 chemoembolization Effects 0.000 title claims abstract description 17
- 206010073071 hepatocellular carcinoma Diseases 0.000 title claims abstract description 13
- 231100000844 hepatocellular carcinoma Toxicity 0.000 title claims abstract description 13
- 210000000582 semen Anatomy 0.000 claims abstract description 17
- 239000002994 raw material Substances 0.000 claims abstract description 16
- 239000010271 massa medicata fermentata Substances 0.000 claims abstract description 14
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims abstract description 13
- 241000756943 Codonopsis Species 0.000 claims abstract description 12
- 241000222640 Polyporus Species 0.000 claims abstract description 12
- 210000003038 endothelium Anatomy 0.000 claims abstract description 12
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims abstract description 12
- 210000004185 liver Anatomy 0.000 abstract description 22
- 230000000694 effects Effects 0.000 abstract description 14
- 210000000952 spleen Anatomy 0.000 description 29
- 210000004369 blood Anatomy 0.000 description 22
- 239000008280 blood Substances 0.000 description 22
- 206010062717 Increased upper airway secretion Diseases 0.000 description 15
- 208000026435 phlegm Diseases 0.000 description 15
- 206010037660 Pyrexia Diseases 0.000 description 14
- 210000002784 stomach Anatomy 0.000 description 12
- 206010028980 Neoplasm Diseases 0.000 description 11
- 208000002193 Pain Diseases 0.000 description 11
- 230000001105 regulatory effect Effects 0.000 description 11
- 230000001737 promoting effect Effects 0.000 description 9
- 229940079593 drug Drugs 0.000 description 8
- 206010011224 Cough Diseases 0.000 description 7
- 208000019790 abdominal distention Diseases 0.000 description 7
- 230000017531 blood circulation Effects 0.000 description 7
- 235000009508 confectionery Nutrition 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 206010012735 Diarrhoea Diseases 0.000 description 6
- 201000011510 cancer Diseases 0.000 description 6
- 230000029087 digestion Effects 0.000 description 6
- 201000000736 Amenorrhea Diseases 0.000 description 5
- 206010001928 Amenorrhoea Diseases 0.000 description 5
- 208000006820 Arthralgia Diseases 0.000 description 5
- 206010023126 Jaundice Diseases 0.000 description 5
- 206010030113 Oedema Diseases 0.000 description 5
- 206010047700 Vomiting Diseases 0.000 description 5
- 210000001015 abdomen Anatomy 0.000 description 5
- 231100000540 amenorrhea Toxicity 0.000 description 5
- 230000007812 deficiency Effects 0.000 description 5
- 238000001035 drying Methods 0.000 description 5
- 208000001848 dysentery Diseases 0.000 description 5
- 208000001780 epistaxis Diseases 0.000 description 5
- 239000000796 flavoring agent Substances 0.000 description 5
- 235000019634 flavors Nutrition 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 210000000232 gallbladder Anatomy 0.000 description 5
- 230000023597 hemostasis Effects 0.000 description 5
- 241000411851 herbal medicine Species 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 201000004792 malaria Diseases 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 231100000614 poison Toxicity 0.000 description 5
- 238000002560 therapeutic procedure Methods 0.000 description 5
- 208000019255 Menstrual disease Diseases 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 210000000038 chest Anatomy 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 239000008187 granular material Substances 0.000 description 4
- 238000000227 grinding Methods 0.000 description 4
- 210000002767 hepatic artery Anatomy 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 201000007270 liver cancer Diseases 0.000 description 4
- 230000003908 liver function Effects 0.000 description 4
- 208000014018 liver neoplasm Diseases 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 238000007873 sieving Methods 0.000 description 4
- 230000004206 stomach function Effects 0.000 description 4
- 238000012549 training Methods 0.000 description 4
- 230000008673 vomiting Effects 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 3
- 208000005171 Dysmenorrhea Diseases 0.000 description 3
- 206010013935 Dysmenorrhoea Diseases 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 3
- 230000036528 appetite Effects 0.000 description 3
- 235000019789 appetite Nutrition 0.000 description 3
- 208000002894 beriberi Diseases 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 206010013990 dysuria Diseases 0.000 description 3
- 230000002440 hepatic effect Effects 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 239000002574 poison Substances 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 230000004083 survival effect Effects 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 206010008531 Chills Diseases 0.000 description 2
- 208000015220 Febrile disease Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 208000025747 Rheumatic disease Diseases 0.000 description 2
- 208000031971 Yin Deficiency Diseases 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- -1 antiinflammatory Substances 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 208000019902 chronic diarrheal disease Diseases 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000001605 fetal effect Effects 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 206010025482 malaise Diseases 0.000 description 2
- 230000002175 menstrual effect Effects 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 230000002980 postoperative effect Effects 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000001047 pyretic effect Effects 0.000 description 2
- 230000000552 rheumatic effect Effects 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 230000005760 tumorsuppression Effects 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010054196 Affect lability Diseases 0.000 description 1
- 206010065553 Bone marrow failure Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 208000001140 Night Blindness Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 206010040007 Sense of oppression Diseases 0.000 description 1
- 206010067868 Skin mass Diseases 0.000 description 1
- 208000026137 Soft tissue injury Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 206010044302 Tracheitis Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 206010046814 Uterine prolapse Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 210000001105 femoral artery Anatomy 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 230000002008 hemorrhagic effect Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical compound OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 1
- 210000003240 portal vein Anatomy 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000002633 protecting effect Effects 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000001604 vasa vasorum Anatomy 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
一种用于中晚期肝癌化疗栓塞后的药,它由原材料按重量比组成:党参4.2-12.5%、苍术2.7-6.5%、白术2.7-6.5%、猪苓4.2-12.5%、茯苓4.2-12.5%、半夏2.64.5%、陈皮4-6.7%、柴胡2.6-4.5%、白芍4.2-12.5%、当归4.2-12.5%、薏米4.2-12.5%、茵陈4.2-12.5%、牡丹皮2.7-6.5%、郁金2.7-6.5%、鸡内金2.7-6.5%、焦三仙8.4-18.7%、甘草1.6-2.7%,因而,能对患者的肝功能保护、增强疗效、提高生命质量、延长病人生命、减轻家庭经济负担,特别适合于中晚期肝癌化疗栓塞后之用。
Description
技术领域:
本发明涉及一种治疗中晚期肝癌的药,特别是一种对中晚期肝癌患者进行肝动脉化疗栓塞后服用的中草药。
背景技术:
肝癌是消化系统中一种最常见的恶性肿瘤,近期发病率上升趋势明显,在治疗中大都采用手术、介入、保守治疗,随着社会的发展,介入治疗成为人们的首选,主要由于介入治疗是一种微创、安全性高的手术,人体受伤害的程度较少,但是,多次的介入治疗对病人的肝功能损害较大,病人的精神和生活质量以及家庭的经济负担都有极大的影响,目前,实行介入治疗的病人后只能通过西药进行治疗,特别是术后6-24小时,病人的体力很虚,可使病人已虚的正气更虚,抗癌力进一步下降,为残存癌毒的复发转移提供了有利条件,西药的成本较高,病人的负担比较重,同时,西药有一定的副作用,长期服用,还能产生一定的不良反应,现在,我国还没有一种利用中草药对中晚期肝癌患者进行肝动脉化疗栓塞后进行保肝护肝。
发明任务:
本发明的目的就是要提供一种对患者的肝功能保护、增强疗效、提高生命质量、延长病人生命、减轻家庭经济负担的治疗中晚期肝癌化疗栓塞后的药。
本发明的目的是这样实现的:一种治疗中晚期肝癌化疗栓塞后的药,其特征在于它由原材料按重量比组成:党参4.2-12.5%、苍术2.7-6.5%、白术2.7-6.5%、猪苓4.2-12.5%、茯苓4.2-12.5%、半夏2.6-4.5%、陈皮4-6.7%、柴胡2.6-4.5%、白芍4.2-12.5%、当归4.2-12.5%、薏米4.2-12.5%、茵陈4.2-12.5%、牡丹皮2.7-6.5%、郁金2.7-6.5%、鸡内金2.7-6.5%、焦三仙8.4-18.7%、甘草1.6-2.7%。
本发明所述的治疗中晚期肝癌化疗栓塞后的药,它由原材料按重量比组成:党参4.9-10%、苍术3.3-5%、白术3.3-5%、猪苓4.9-10%、茯苓4.9-10%、半夏3-3.5%、陈皮4.5-5%、柴胡3-3.5%、白芍4.9-10%、当归4.9-10%、薏米4.9-10%、茵陈4.9-10%、牡丹皮3.3-5%、郁金3.3-5%、鸡内金3.3-5%、焦三仙10-14.8%、甘草1.8-2.2%。
本发明所述的治疗中晚期肝癌化疗栓塞后的药,它还包含以下按重量比的原材料:青蒿4.9-10%、白薇3.3-5%。
本发明所述的治疗中晚期肝癌化疗栓塞后的药,它还包含以下按重量比的原材料:砂仁3-3.5%%、大腹皮9.5-10.5%、莱菔子9.5-10.5%。
本发明所述的治疗中晚期肝癌化疗栓塞后的药,它还包含以下按重量比的原材料:茜草4.5-5%、仙鹤草9.5-10.5%、侧柏叶4.5-5%。
本发明所述的治疗中晚期肝癌化疗栓塞后的药以制作为汤汁为主,还可制作呈药丸、胶囊、药末冲剂。
肝癌主要由肝动脉分支的肿瘤滋养血管供应整体瘤体,在肿瘤细胞生长活跃的肿瘤周边区域,则同时存在着许多门静脉分支,当肝内发生肿瘤时,其肿瘤供血可通过吻合支从邻近动脉获得血供,肝癌的供血90%-95%以上来自肝动脉,故通过肝动脉插管给药,可使药物直接进入肝癌组织,大大提高了局部的药物浓度,对细胞进行最大程度的杀伤,介入后通过中草药进行配合治疗,起到减毒增效的作用,可以避免恶心、呕吐、食欲下降等消化道副作用,可以减轻化疗所引起的骨髓抑制反应,可避免可能出现的白细胞、血小板下降现象,加强对肝功能的保护,避免介入药物直接作用于肝脏而引起的肝功能的损害;由于中草药具有杀瘤、抑瘤的作用,因而,能最大限度的杀灭癌毒,减少癌毒的复发几率,运用中药改变癌细胞特性,从而起到抑制肿瘤转移的作用。
党参:补中,益气,生津,治脾胃虚弱,气血两亏,体倦无力,食少,口渴,久泻,脱肛;本发明主要用于补气培元;
苍术:性味归经辛、苦,温。归脾、胃、肝经,燥湿健脾,祛风散寒,明目。用于脘腹胀满,泄泻水肿,脚气痿躄,风湿痹痛,风寒感冒,夜盲;本发明主要用于祛湿化痰健脾;
白术:苦、甘,温,归脾、胃经,健脾益气,燥湿利水,止汗,安胎,用于脾虚食少,腹胀泄泻,痰饮眩悸,水肿,自汗,胎动不安;本发明主要用于补气培元;
猪苓:性平,味甘,利水渗湿,主治小便不利,淋沥热痛、水肿等症,并有抗癌作用;本发明主要用于祛湿化痰健脾;
茯苓:味甘、淡、性平,入药具有利水渗湿、益脾和胃、宁心安神之功用,现代医学研究:茯苓能增强机体免疫功能,茯苓多糖有明显的抗肿瘤及保肝脏作用;本发明主要用于补气培元;
半夏:燥湿化痰,降逆止呕,消痞散结,主治咳喘痰多,呕吐反胃,胸脘痞满头痛眩晕,夜卧不安,瘿瘤痰核,痈疽肿毒;本发明主要用于祛湿化痰健脾;
陈皮:具理气降逆、调中开胃、燥湿化痰之功,主治脾胃气滞湿阻、胸膈满闷、脘腹胀痛、不思饮食、呕吐秽逆、二便不利、肺气阻滞、咳嗽痰多,亦治乳痈初起;本发明主要用于祛湿化痰健脾;
柴胡:性味:苦平、归经、入肝、胆经,功能:发表、退热、疏肝、解郁、升阳,主治感冒发烧、寒热往来、疟疾、胁胀痛、月经不调,和解少阳,舒肝和胃,升阳举陷。治寒热往来,胸满胁痛,口苦耳聋,头痛目眩,疟疾,下利脱肛,月经不调,子宫下垂,热入血室;本发明主要用于疏肝活血;
白芍:性味苦酸,凉,养血柔肝,缓中止痛,敛阴收汗,治胸腹胁肋疼痛,泻痢腹痛,自汗盗汗,阴虚发热,月经不调,崩漏,带下;本发明主要用于柔肝养血;
当归:甘、辛,温。归肝、心、脾经,补血活血,调经止痛,润肠通便,用于血虚萎黄、眩晕心悸、月经不调、经闭痛经、虚寒腹痛、肠燥便秘、风湿痹痛、跌扑损伤、痈疽疮疡;本发明主要用于柔肝养血;
薏米:性味性凉,味甘、淡,健脾渗湿,除痹止泻,可用于治疗水肿、脚气、小便不利、湿痹拘挛、脾虚泄泻;本发明主要用于祛湿化痰健脾;
茵陈:苦、辛,微寒,归脾、胃、肝、胆经,清湿热,退黄疸,用于黄疸尿少、湿疮瘙痒、传染性黄疸型肝炎,.药理学研究有利胆,保护肝功能,解热,抗炎,降血脂,降压,扩冠等作用;本发明主要用于疏肝活血;
牡丹皮:清热;活血散瘀,主温热病热入血分;发斑;吐衄;热泪盈眶病菌后期热伏阴分发热;阴虚骨蒸潮热;血滞经闭;痛经;痈肿疮毒;跌扑伤痛;风湿热痹;本发明主要用于疏肝活血;
郁金:辛、苦,寒,归肝、心、肺经,行气化瘀,清心解郁,利胆退黄。用于经闭痛经,胸腹胀痛、刺痛,热病神昏,癫痫发狂,黄疸尿赤;本发明主要用于疏肝活血;
鸡内金:甘,平,涩,脾经,健脾消食,涩精止遗,消症化石,主消化不良,泻痢,疳积,遗精遗尿,泌尿系结石,胆结石,症瘕经闭;本发明主要用于和胃消食;
焦三仙:即为焦麦芽、焦山楂、焦神曲,这三味药均有良好的消积化滞功能,但又有各自不同的特点,焦麦芽有很好的消化淀粉类食物的作用;焦山楂善于治疗肉类或油腻过多所致的食滞;焦神曲则利于消化米面食物,三药合用,能明显地增强消化功能;本发明主要用于和胃消食;
甘草:补脾益气,清热解毒,祛痰止咳,缓急止痛,调和诸药,用于脾胃虚弱,倦怠乏力,心悸气短,咳嗽痰多,脘腹、四肢挛急疼痛,痈肿疮毒,缓解药物毒性、烈性;本发明主要用于补气培元;
青蒿:苦、辛,寒,归肝、胆经,清透虚热,凉血除蒸,解暑,截疟;本发明主要用于退虚热;
白薇:味苦,咸,性寒,主治温热,身热斑疹,潮热骨蒸,肺热咳嗽,产后虚烦,热淋,血淋,咽喉肿痛,疮痈肿毒,毒蛇咬伤;本发明主要用于退虚热;
砂仁:性味归经:辛,温,归脾、胃、肾经,主治化湿开胃,温脾止泻,理气安胎,用于湿浊中阻,脘痞不饥,脾胃虚寒,呕吐泄泻,妊娠恶阻,胎动不安;本发明主要用于理气消胀;
大腹皮:味辛,性微温,归脾,胃,大肠,小肠经,下气宽中,行水消肿,用于湿阻气滞,胸腹胀闷,大便不爽,水肿,脚气,小便不利;本发明主要用于理气消胀;
莱菔子::性平,味辛、甘,归肺、脾、胃经,消食除胀,降气化痰,用于饮食停滞、脘腹胀痛、大便秘结、积滞泻痢、痰壅喘咳,入脾、胃、肺经,能消食除胀,功效显著,有“冲墙倒壁”之称,临床习用于治疗实(食、湿、积滞)症;本发明主要用于理气消胀;
茜草:苦,归肝经,凉血,止血,祛瘀,通经,镇咳,祛痰,用于吐血,衄血,崩漏,外伤出血,经闭瘀阻,关节痹痛,跌扑肿痛,可以治疗出血性疾患,慢性气管炎,慢性腹泻,风湿性关节炎,治疗软组织损伤,治疗白细胞减少症;本发明主要用于凉血止血;
仙鹤草:苦、涩,平,归心、肝经,收敛止血,截疟,止痢,解毒,用于咳血,吐血,崩漏下血,疟疾,血痢,脱力劳伤,痈肿疮毒,阴痒带下;本发明主要用于凉血止血;
侧柏叶:苦、涩,寒,归肺、肝、脾经,凉血止血,化痰止咳,生发乌发;本发明主要用于凉血止血。
以上诸药配伍,起到健脾和胃以生气血、祛痰活血以通经隧、补而不滞、祛邪不伤正气之功效,且制作简单、服用方便、无毒副作用、价格低廉。
本发明通过临床试验具有良好效果,对两组60例中晚期癌症患者均采用Seldinger技术经皮股动脉穿刺,将导管置入肝动脉和供血动脉进行化疗栓塞;A组为单纯的肝动脉化疗栓塞,B组为术后进行中药治疗,两组比较见表1、2
表1:生存率情况
0.5年 | 1年 | 2年 | 3年 | |
A组 | 90.5% | 80.4% | 45% | 20.1% |
B组 | 96% | 86.5% | 68.2% | 35.5% |
表2:生活质量情况(生存期内症状出现率)
腹痛 | 发热 | 消化道症状 | 其他 | |
A组 | 22.6% | 19.9% | 69.9% | 38.8% |
B组 | 11.6% | 3% | 6% |
通过上述两个表可以看出,B组患者的生存率明显高于A组,尤其第3年的生存率,经统计学X2检验,显示有明显差异(p<005),说明中药的治疗有益于长期的疗效;生活质量方面,B组患者的也明显高于A组,且统计学上有明显差异(p<005),说明中药配合治疗的病人能获得较好的生存质量;其他指影响患者生活质量的其他因素,如乏力、情绪不稳、睡眠不好等;通过中草药的治疗,3年后尚有12例患者存活,目前病情稳定。
具体实施方式:
实施例1:以制作一副药剂为例,取党参30克、苍术15克、白术15克、猪苓15克、茯苓15克、半夏10克、陈皮15克、柴胡10克、白芍30克、当归15克、薏米30克、茵陈30克、牡丹皮15克、郁金10克、鸡内金10克、焦三仙各10克、甘草6克;先将上述原材料混合好放到药罐里,再放上生姜3片,然后向药罐中注入水,水要浸过草药,浸泡20-30分钟后进行煎熬,共煎2次,取汁400-500升,1-2天服完,此配方适合于所有的病人。
实施例2:以制作一副药剂为例,取党参15克、苍术10克、白术10克、猪苓30克、茯苓30克、半夏10克、陈皮15克、柴胡10克、白芍15克、当归20克、薏米30克、茵陈15克、牡丹皮10克、郁金15克、鸡内金15克、焦三仙各15克、甘草6克、青蒿30克、白薇15克;制作方法同实施例1,此配方适合于发低烧的病人。
实施例3:以制作一副药剂为例,取党参30克、苍术15克、白术15克、猪苓15克、茯苓15克、半夏10克、陈皮15克、柴胡10克、白芍30克、当归15克、薏米30克、茵陈30克、牡丹皮10克、郁金15克、鸡内金10克、焦三仙各10克、甘草6克、砂仁10克、大腹皮30克、莱菔子30克;制作方法同实施例1,此配方适合于腹胀的病人。
实施例4:以制作一副药剂为例,取党参30克、苍术15克、白术15克、猪苓15克、茯苓15克、半夏10克、陈皮15克、柴胡10克、白芍30克、当归30克、薏米15克、茵陈30克、牡丹皮15克、郁金10克、鸡内金10克、焦三仙各10克、甘草6克、茜草15克、仙鹤草30克、侧柏叶15克;制作方法同实施例1,此配方适合于牙鼻出血的病人。
实施例5:以制作一副药为例,取党参30克、苍术15克、白术15克、猪苓30克、茯苓30克、半夏10克、陈皮15克、柴胡10克、白芍30克、当归15克、薏米30克、茵陈15克、牡丹皮10克、郁金15克、鸡内金15克、焦三仙各15克、甘草6克;如果病人发低烧再加入青蒿15克、白薇10克;如果病人腹胀再加入砂仁10克、大腹皮30克、莱菔子30克;如果病人牙鼻出血再加入茜草15克、仙鹤草30克、侧柏叶15克;首先将上述原材料混合好,进行清洗干净;再将清洗好的原材料放入烘干箱中进行烘干,然后进行研磨成颗粒状,再用100目的筛子将研磨好的原材料进行过筛,颗粒小的药过滤出来,以备后用,颗粒大的再进行研末过筛,最终达到过筛的目的;然后将1千克蜂蜜放入锅中用微火炼制,凝如饴状,搅之勿令焦;最后将炼蜜与上述药末混合揉按均匀,放置约半小时,再次揉按,制成6克左右的蜜丸即可,分1-2天服完。
实施例6、以制作一副药为例,取党参30克、苍术15克、白术15克、猪苓15克、茯苓15克、半夏10克、陈皮15克、柴胡10克、白芍30克、当归15克、薏米30克、茵陈30克、牡丹皮15克、郁金10克、鸡内金10克、焦三仙各10克、甘草6克;如果病人发低烧再加入青蒿15克、白薇10克;如果病人腹胀再加入砂仁10克、大腹皮30克、莱菔子30克;如果病人牙鼻出血再加入茜草15克、仙鹤草30克、侧柏叶15克;首先将上述原材料混合好,进行清洗干净;再将清洗好的原材料放入烘干箱中进行烘干,然后进行研磨成颗粒状,再用100目的筛子将研磨好的原材料进行过筛,颗粒小的药过滤出来,以备后用,颗粒大的再进行研末过筛,最终达到过筛的目的;最后以6克为单位装袋即可,分1-2天服完。
实施例7:以制作一副药为例,原材料的配比同实施例6;制作方法与实施例6不同的是最后以0.5克装入胶囊即可,分1-2天服完。
Claims (2)
1.一种用于中晚期肝癌化疗栓塞后的药,其特征在于它由以下原材料按重量比组成:党参4.2-12.5%、苍术2.7-6.5%、白术2.7-6.5%、猪苓4.2-12.5%、茯苓4.2-12.5%、半夏2.6-4.5%、陈皮4-6.7%、柴胡2.6-4.5%、白芍4.2-12.5%、当归4.2-12.5%、薏米4.2-12.5%、茵陈4.2-12.5%、牡丹皮2.7-6.5%、郁金2.7-6.5%、鸡内金2.7-6.5%、焦三仙8.4-18.7%、甘草1.6-2.7%。
2.根据权利要求1所述的一种用于中晚期肝癌化疗栓塞后的药,其特征在于它由以下原材料按重量比组成:党参4.9-10%、苍术3.3-5%、白术3.3-5%、猪苓4.9-10%、茯苓4.9-10%、半夏3-3.5%、陈皮4.5-5%、柴胡3-3.5%、白芍4.9-10%、当归4.9-10%、薏米4.9-10%、茵陈4.9-10%、牡丹皮3.3-5%、郁金3.3-5%、鸡内金3.3-5%、焦三仙10-14.8%、甘草1.8-2.2%。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110027563.6A CN102106991B (zh) | 2011-01-20 | 2011-01-20 | 一种用于中晚期肝癌化疗栓塞后的药 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110027563.6A CN102106991B (zh) | 2011-01-20 | 2011-01-20 | 一种用于中晚期肝癌化疗栓塞后的药 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102106991A CN102106991A (zh) | 2011-06-29 |
CN102106991B true CN102106991B (zh) | 2015-08-26 |
Family
ID=44171347
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201110027563.6A Expired - Fee Related CN102106991B (zh) | 2011-01-20 | 2011-01-20 | 一种用于中晚期肝癌化疗栓塞后的药 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102106991B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104274781B (zh) * | 2014-10-27 | 2017-07-28 | 王叶颖 | 一种治疗因肝癌致食欲不佳的中药制剂及其制备方法 |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102302731B (zh) * | 2011-08-15 | 2013-05-01 | 于水莲 | 一种治疗肋痛的中药组合物 |
CN103908640B (zh) * | 2014-04-25 | 2016-05-04 | 解建峰 | 一种治疗肝硬化的中药组合物 |
CN104138574A (zh) * | 2014-07-21 | 2014-11-12 | 济南环太机电技术有限公司 | 一种治疗婴儿臌胀的中药汤剂 |
CN104147452A (zh) * | 2014-08-19 | 2014-11-19 | 陈学波 | 治疗中晚期肝癌的药 |
CN104189771A (zh) * | 2014-09-19 | 2014-12-10 | 侯美霞 | 一种预防化疗反应的中药制剂 |
CN105535898A (zh) * | 2016-01-07 | 2016-05-04 | 青岛市肿瘤医院 | 一种治疗脾虚湿困型早期肝癌的中药配方 |
CN105851786A (zh) * | 2016-03-31 | 2016-08-17 | 韩常英 | 对肝癌患者化疗具有增效作用的保健药膳及制法 |
CN110638956B (zh) * | 2019-10-30 | 2021-11-02 | 中国人民解放军总医院第五医学中心 | 一种用于抗肿瘤的药物组合物及其应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1111148A (zh) * | 1995-02-25 | 1995-11-08 | 王存民 | 近视穴敷液 |
CN1113779A (zh) * | 1994-06-17 | 1995-12-27 | 殷广全 | 抗乙肝制剂 |
CN1142376A (zh) * | 1995-08-04 | 1997-02-12 | 窦金清 | 一种治疗宫颈疾患的药物 |
-
2011
- 2011-01-20 CN CN201110027563.6A patent/CN102106991B/zh not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1113779A (zh) * | 1994-06-17 | 1995-12-27 | 殷广全 | 抗乙肝制剂 |
CN1111148A (zh) * | 1995-02-25 | 1995-11-08 | 王存民 | 近视穴敷液 |
CN1142376A (zh) * | 1995-08-04 | 1997-02-12 | 窦金清 | 一种治疗宫颈疾患的药物 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104274781B (zh) * | 2014-10-27 | 2017-07-28 | 王叶颖 | 一种治疗因肝癌致食欲不佳的中药制剂及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN102106991A (zh) | 2011-06-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102106991B (zh) | 一种用于中晚期肝癌化疗栓塞后的药 | |
CN102552855B (zh) | 一种治疗胃胀的药物及其制备方法 | |
CN103690919B (zh) | 用于治疗仔猪缺铁性贫血的药物及其制备方法 | |
CN105815543A (zh) | 一种畜禽饲料中草药添加剂 | |
CN105477614A (zh) | 一种治疗肥胖的药物及其制备方法 | |
CN103920051B (zh) | 一种治疗小儿疳积的药物及制备方法 | |
CN103432412B (zh) | 一种治疗乳腺增生的药物及其制备方法 | |
CN103611011B (zh) | 一种治疗产后缺乳的药物 | |
CN102293964B (zh) | 一种治疗胃溃疡的药物及其制备方法 | |
CN105079676A (zh) | 一种治疗脂肪肝的药物及其制备方法 | |
CN106036028A (zh) | 一种能降低胆固醇且免用抗生素的畜禽饲料 | |
CN104758915A (zh) | 一种治疗产后血虚气脱的中药 | |
CN103550622B (zh) | 一种用于产后回乳的中药 | |
CN104367827A (zh) | 一种治疗脾气虚弱证型多寐病的中药 | |
CN102988883B (zh) | 一种治疗肝炎的药物及其制备方法 | |
CN101810751B (zh) | 一种治疗小儿肠系膜淋巴结发炎的中药制剂 | |
CN104147452A (zh) | 治疗中晚期肝癌的药 | |
CN106377659A (zh) | 一种用于防治畜禽温热性疾病的中药粉剂及其制备方法 | |
CN105362907A (zh) | 一种治疗乳腺囊肿的泡腾片及其制备方法 | |
CN106266704A (zh) | 治疗肠胃炎的中药组合物及制备方法 | |
CN105343863A (zh) | 一种治疗良性卵巢囊肿的药物及其制备方法 | |
CN105343854A (zh) | 一种治疗胃脘痛的药物及其制备方法 | |
CN105435187A (zh) | 一种治疗干燥病的药物及其制备方法 | |
CN104056228A (zh) | 一种治疗小儿厌食症的药物及其制备方法 | |
CN103861034B (zh) | 一种消食的中药及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150826 Termination date: 20160120 |
|
EXPY | Termination of patent right or utility model |